SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-014921
Filing Date
2019-03-15
Accepted
2019-03-14 19:22:25
Documents
3
Period of Report
2019-03-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-6325_38k.htm 8-K 26446
2 EX-1.1 a19-6325_3ex1d1.htm EX-1.1 338694
3 EX-5.1 a19-6325_3ex5d1.htm EX-5.1 15189
  Complete submission text file 0001104659-19-014921.txt   381582
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 19682520
SIC: 2834 Pharmaceutical Preparations